Xeljanz Interactions
There are 660 drugs known to interact with Xeljanz (tofacitinib), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 378 are major, 271 are moderate, and 11 are minor.
- View all 660 medications that may interact with Xeljanz
- View Xeljanz alcohol/food interactions (2)
- View Xeljanz disease interactions (13)
Most frequently checked interactions
View interaction reports for Xeljanz (tofacitinib) and the medicines listed below.
- albuterol
- amlodipine
- atorvastatin
- Cymbalta (duloxetine)
- doxycycline
- duloxetine
- folic acid
- gabapentin
- Humira (adalimumab)
- hydroxychloroquine
- leflunomide
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- meloxicam
- metformin
- methotrexate
- montelukast
- omeprazole
- pantoprazole
- Plaquenil (hydroxychloroquine)
- prednisone
- tizanidine
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Xeljanz alcohol/food interactions
There are 2 alcohol/food interactions with Xeljanz (tofacitinib).
Xeljanz disease interactions
There are 13 disease interactions with Xeljanz (tofacitinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- tuberculosis
- viral reactivation
- cytopenias
- diabetes
- GI obstruction
- GI perforation
- hepatic disorder
- hyperlipidemia
- renal disease
Report options
More about Xeljanz (tofacitinib)
- Xeljanz consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (145)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Hydrocortisone
Hydrocortisone systemic is used for addison's disease, adrenocortical insufficiency, asthma, acute ...
Budesonide
Oral budesonide is used to treat the following conditions with inflammation as a symptom ...
Hydroxychloroquine
Hydroxychloroquine is a quinoline drug used to treat or prevent malaria. It's also used to treat ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
